APA (7th ed.) Citation

S, R., N, G., F, E., B, L., JP, F., D, Z., . . . A, G. (2026). Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. MedComm, 7(3), e70634. https://doi.org/10.1002/mco2.70634

Chicago Style (17th ed.) Citation

S, Ravassa, et al. "Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics." MedComm 7, no. 3 (2026): e70634. https://doi.org/10.1002/mco2.70634.

MLA (9th ed.) Citation

S, Ravassa, et al. "Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics." MedComm, vol. 7, no. 3, 2026, p. e70634, https://doi.org/10.1002/mco2.70634.